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BIOPSY OF SUSPICIOUS OSSEOUS LESIONS IN PATIENTS WITH A KNOWN PRIMARY MALIGNANCY: RATE OF ALTERNATE DIAGNOSIS
AND COMPLICATION RATE.
Alexander Grushky, MD1; Christopher Nall, MD1; Zakaria Aqel, MD1; Alyssa Kirsch, MD1; Jonathan Im, MS2
1
Beaumont Health System, Royal Oak, MI, USA; 2Michigan State University College of Human Medicine, Grand Rapids, MI, USA
(Presented by: Alexander Grushky, MD, Beaumont Health System)
Purpose: In patients with multiple suspicious osseous lesions in the setting of a known primary malignancy, we sought to determine
the rate at which tissue sampling of these osseous lesions yielded a different diagnosis from the primary malignancy. Secondary
objective included determination of the complication rate in these biopsy procedures, including the need for re‐biopsy.
Materials and Methods: Medical records for patients undergoing CT guided biopsy of a suspicious osseous lesion were retrospectively
reviewed over a 12 month period from 2017 to 2018. There were 78 patients that underwent CT guided biopsy. Inclusion criteria for
this study included: known primary cancer diagnosis, greater than three suspicious osseous lesion, and targeted CT guided biopsy
performed by a musculoskeletal radiologist. The results of the biopsy lesions were then categorized as matched pathologic diagnosis,
alternate pathologic diagnosis, no evidence of malignancy, and non‐diagnostic or unsatisfactory sample.
Results: There were a total of 34 out of 80 CT guided biopsies that met the inclusion criteria. Of those included, 74% (n= 25) had
matched pathologic diagnosis, 9% (n= 3) had an alternative pathologic diagnosis, 9% (n= 3) had no evidence of malignancy, and 9%
(n= 3) had a non‐diagnostic or unsatisfactory sample. Alternative diagnosis included: breast cancer with different receptor profile,
bone island, and adenocarcinoma unspecified. Of the 34 bone biopsies, no immediate post‐procedural complications were identified,
and 3% required a re‐biopsy (n= 1).
Conclusion: In patients with known primary malignancy and multiple suspicious osseous lesions, CT‐guided biopsy of a suspicious
osseous lesion represented matched pathologic diagnosis of the primary malignancy in 74% of cases. An alternative diagnosis was
obtained in 9% of cases, and there was no evidence of malignancy in 9% of cases. Our results suggest that given the rate of alternative
pathologic diagnosis in this patient population, careful consideration should be made when determining the need for biopsy
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